Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on DC STEM Digest.
Launch of GIST USA’s ‘Nutrition360' Program Across Indian Consulates in the United States on Ayurveda Day 2025
In a historic and coordinated celebration of Ayurveda Day 2025, 6 Indian Consulates jointly launched the Nutrition360 Program, a flagship initiative of GIST USA NEW YORK, NY, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- In a historic...
Maris-Tech to Demonstrate AI-Powered Situational Awareness and Edge Computing Solutions at AUSA 2025
Live demonstrations in Hall B, Booth 2154, Washington D.C. Rehovot, Israel, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”) –...
Forterra, RTX’s Raytheon and Oshkosh Showcase DeepFires™ Autonomous Launcher Prototypes at AUSA 2025
Washington, D.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- WASHINGTON, D.C., Oct. 7, 2025 — Forterra, the leader in autonomous mission systems, in collaboration with Raytheon, an RTX business, the world’s largest aerospace and defense company, and...
Mobilicom Launches Secured AutonomyTM: Industry’s First Comprehensive Cybersecurity Framework for Autonomous Drones and Robotics
Expands Mobilicom’s addressable markets with growing portfolio of partnered solutions that integrate the Company’s cybersecurity software into partners’ next-generation AI-driven hardware and software solutions to deliver safe and secure...
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular...
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered using Dewpoint’s AI/ML and condensate...
Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
– Gavel brings highly relevant CAR T experience from Legend Biotech where he led the launch and commercialization of CARVYKTI® from 2018 until 2025 – PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a...
New Report: Vast Majority of Recent Public College Graduates See Return on College Investment Within 10 Years
INDIANAPOLIS, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Seventy percent of America’s recent public college graduates experience a positive return on investment within 10 years of graduation, a figure that falls short of the goal that all graduates see...
Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation
CHATHAM, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated biotechnology company with marketed products and a pipeline of development candidates, today...
Bombardier Defense and SNC Announce 10-year Service Agreement in Support of U.S. Military Program
Agreement covers two Bombardier Global 6500 aircraft – equipped with SNC’s RAPCON-X® technology – that SNC owns and operates for a U.S. military customer SNC will benefit from the Bombardier Smart Services Defense program, which allows for...
Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers
TARRYTOWN, N.Y., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its advancing oncology pipeline will be shared in seven abstracts at the European Society for Medical...
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, in collaboration with its Canadian partner HLS Therapeutics, a...
TexStar Chiropractic Expands Leading Chiropractic Care in South Austin
South Austin clinic delivers modern, evidence-based chiropractic care with advanced technology and a patient-first approach. AUSTIN, TX, UNITED STATES, October 14, 2025 /EINPresswire.com/ -- TexStar Chiropractic, one of Central Texas’ most...
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
MALVERN, Pa., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease...
AAFA Responds to Study on Inhalers and Greenhouse Gas Emissions and Their Effect on Climate
Washington D.C., Oct. 09, 2025 (GLOBE NEWSWIRE) -- A new study published in JAMA finds that the propellants in metered-dose inhalers (MDIs) for the treatment of asthma and COPD contribute significantly to greenhouse gas emissions. The Asthma and...
ACCUCOLD EXPANDS THE PERFORMANCE SERIES WITH DUAL COMPRESSOR REFRIGERATOR-FREEZERS
The Cold Storage Manufacturer Introduces All-In-One Combinations BRONX, NY, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- Felix Storch, Inc. (FSI), a leading provider of purpose-built medical and life science refrigeration through its...
Chairman Capito Opening Statement at Hearing to Consider NRC, EPA Nominees
WASHINGTON, D.C. – Today, U.S. Senator Shelley Moore Capito (R-W.Va.), Chairman of the Senate Environment and Public Works (EPW) Committee, led a hearing on the nominations of Ho Nieh to be a Member of the Nuclear Regulatory Commission (NRC) and...
Owner: American Government
Remix Therapeutics to Present Phase 1 Data of REM-422 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Conference in Late-Breaking Oral Presentation
WATERTOWN, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced...
Whitehouse Opening Statement at NRC, EPA Nominations Hearing
Washington, D.C.—Today, Senator Sheldon Whitehouse (D-R.I.), Ranking Member of the U.S. Senate Environment and Public Works (EPW) Committee, delivered the following opening statement at today’s hearing, “Hearing on the Nominations of Ho Nieh to be...
Owner: American Government